The Trump administration will stop making cost-sharing reduction payments to health insurers, the White House announced last night. Insurers use the federal payments to reduce out-of-pocket costs for low-income individuals purchasing coverage through the Health Insurance Marketplaces. The Congressional Budget Office in August estimated that premiums for silver-level plans would be 20% higher in 2018 and 25% higher in 2026 if the CSR payments were to end. CBO also estimated the changes would increase the federal deficit by $194 billion from 2018 through 2026. 

Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…
Headline
The Centers for Medicare & Medicaid Services June 1 issued an interim final rule with comment period implementing the statutory requirement that certain…
Headline
The Centers for Medicare & Medicaid Services May 20 released a proposed rule that would modify policies governing Medicaid state-directed…
Headline
The White House May 18 announced an expansion of TrumpRx.gov, which now features more than 600 generic drugs. The direct-to-consumer platform serves as a hub…
Headline
A blog by Noah Isserman, AHA director of health insurance and coverage policy, explains why Anthem’s nonparticipating provider policy limits patients’ …
Blog
Public
Patients are best served when insurers act as transparent and reasonable partners, not when they invoke patient protection laws to justify payment strategies…